- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | J&J's Tremfya approved by MHRA to treat Crohn's disease and ulcerative colitis | ||
| Di | FDA approves Fujirebio's Lumipulse as first Alzheimer's disease blood test | ||
| Di | Alnylam shares phase 3 results for Amvuttra in rare heart disease ATTR-CM | ||
| Mo | AbbVie and ADARx enter multi-billion dollar partnership to develop siRNA therapies | ||
| Mo | Sanofi unveils $20bn US investment to boost R&D and manufacturing presence | ||
| Mo | Merck receives MHRA approval for adult-specific pneumococcal vaccine Capvaxive | ||
| Fr | Novo Nordisk and Septerna enter $2.2bn cardiometabolic disease partnership | ||
| Fr | AbbVie's Emrelis granted FDA accelerated approval to treat advanced lung cancer | ||
| Fr | Eli Lilly to expand long-standing Purdue University partnership with $250m investment | ||
| Do | GSK to acquire Boston's liver disease candidate efimosfermin in deal worth up to $2bn | ||
| Do | Cytokinetics shares positive phase 3 results for aficamten in heart disease | ||
| Do | Madrigal's liver disease drug Rezdiffra shows promise in compensated MASH cirrhosis | ||
| 14.05. | Roche's Perjeta-based breast cancer regimen shows sustained survival benefits | ||
| 14.05. | Johnson & Johnson's bladder cancer therapy Balversa accepted by SMC | ||
| 14.05. | Eli Lilly's Zepbound shows superiority in head-to-head weight loss study | ||
| 13.05. | Takeda's Adzynma approved by MHRA for rare blood clotting disorder cTTP | ||
| 13.05. | AstraZeneca announces positive phase 3 results for Imfinzi in high-risk bladder cancer | ||
| 13.05. | Novo Nordisk's Wegovy shows early protection against heart disease | ||
| 12.05. | FDA approves Verastem Oncology's combination therapy for rare ovarian cancer type | ||
| 12.05. | J&J/Protagonist's icotrokinra shows promise in difficult-to-treat plaque psoriasis | ||
| 12.05. | GSK shares promising phase 3 results for linerixibat in PBC-related itch | ||
| 09.05. | FDA announces rapid rollout of AI system to accelerate drug review process | ||
| 09.05. | BeiGene's Tevimbra combination granted EC approval in small cell lung cancer | ||
| 09.05. | Inizio Evoke appoints Tristen George and Kevin Kaniuga as executive creative directors | ||
| 09.05. | Apiary invests in life sciences performance marketing specialist performance-io |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .